2025 AAFA Alaska Meeting

Wheezin’, Sneezin’ and Itchin’ in Alaska is a 2-day program that targets a variety of medical specialists who frequently encounter allergy, asthma and immunology patients in their clinical practices. With only 8 board certified allergists/immunologists practicing in Alaska; many Alaskans with asthma and/or allergies who live in urban and rural cities must rely on medical care from general practitioners such as pediatricians, family practice providers, ANP’s, and/or PA’s. Physician and other health care providers from across Alaska, welcome the opportunity to increase their knowledge of asthma, allergy and immunological disease management based on current guidelines. AAFA Alaska’s conference provides local access to state- of- the art education programs, minimizing the amount of travel that would be required to attend similar programs in the continental United States. This conference provides a rigorous program of evidenced based information provided by a carefully selected faculty.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Learn commonly used diagnostic tests in allergy
  • Review allergy diagnostic tools highlighted by clinical scenarios
  • Learn the natural course of allergic rhinitis, common triggers and approach to management
  • Learn which allergic rhinitis therapies and treatments to avoid due to the potential for adverse effects
  • Learn emerging diagnostic modalities in immunoglobulin E (IgE) mediated food allergy diagnosis
  • Understand the role of omalizumab, oral immunotherapy, and intranasal epinephrine in current food allergy management
  • Become familiar with emerging food allergy treatments
  • Learn how environmental exposures like emollients, food intervention and breastfeeding can be used to prevent disease
  • Discuss possible reasons for the increasing prevalence of atopic diseases
  • Describe the ways in which atopic disease may be beneficial. Explain how atopic disease may protect from respiratory viral infections
  • Describe autoinflammatory disorders as clinically unique in the spectrum of inborn immunity errors
  • Recognize the shared and unique clinical presentations of autoinflammatory disorders
  • Learn the initial clinical workup for suspected autoinflammatory disorders, and describe treatment options
  • Outline the components of the immune system. Understand how immune system components work together to prevent infection and repair tissue damage
  • Outline optimal intervention strategies for preschool children with mild persistent asthma and severe episodic wheezing
  • Develop strategies for phenotype directed therapy in preschool children
  • Describe the pathophysiology and clinical presentations typically seen in patients with long COVID
  • Discuss useful approaches to diagnose and treat patients with long COVID
  • Review the efficacy of existing and emerging asthma therapeutics
  • Describe the pathophysiological basis for patients presenting with various forms of angioedema
  • Discuss approaches to efficient diagnosis and effective therapy in managing patients presenting with angioedema
  • Understand the efficacy of systemic agents for atopic dermatitis
  • Understand the efficacy of topical agents for atopic dermatitis
  • Learn about new treatments for atopic dermatitis, including mechanism of action and potential side effects of the agents
  • Distinguish between Type 1 and Type 2b Chronic Spontaneous Urticaria
  • Learn how management differs between autoallergic and autoimmune types of Chronic Sponstaneous Urticaria
  • Discover what’s new at the American College of Allergy Asthma and Immunology (ACAAI)
  • Recognize and describe the pros and cons of artificial intelligence (AI) in various aspects of medicine
  • Understand the future of AI in medicine. Understand effect of rising pollen on allergies and asthma
  • Learn mitigation strategies that can better protect public health
  • Recognize the impact of climate change on increased prevalence and severity of atopic dermatitis
  • Understand the role of climate change in the increased prevalence of food allergy
  • Learn the global impact of climate change on nutrition
  • Discuss cases demonstrating health disparities
  • Understand the framework of health disparities
  • Describe the office strategies to promote health equity
  • Learn about ways to maintaining the three pillars of health – physical, mental and social health - in a changing environment
Summary
Available credit: 
  • 18.25 Attendance
    Attendance credit.
  • 18.25 CE
    CE credit.
  • 18.25 CME
    CME credit.
Course opens: 
09/05/2025
Course expires: 
09/30/2026
Cost:
$0.00
Rating: 
0

The information disclosed by the presenters and planning committee members was reviewed in accordance with the AAAAI Disclosure Policy.  All potential conflicts of interest were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.


Planning Committee

Kathleen A. Bell, RN
Providence Alaska Medical Center
Relevant Relationships: None

Jody Butto, MD
Aurora Pediatrics
Relevant Relationships: None

Jeffrey G. Demain, MD FAAAAI
Lux Infusion
Relevant Relationships: Blueprint Medicine (speaker); Cogent Biosciences, Thermo Fisher (advisory board)

Bryan C. Farthing, PAC
Allergy, Asthma and Immunology Center of Alaska
Relevant Relationships: None

Stephen N. Marks, MD FAAAAI
Allergy, Asthma and Immunology Center of Alaska
Relevant Relationships: None

Laura M. Moore, MD FAAAAI
Allergy, Asthma and Immunology Center of Alaska, LLC
Relevant Relationships: None

Kristina M. Waring, MA, CCC SLP
Kristina Waring SLP; Waring Wellness
Relevant Relationships: None

Jered Weinstock, MD
Providence Alaska Medical Center
Relevant Relationships: None

Kathleen E. Young
WWAMI School of Medical Education
Relevant Relationships: None

 

Faculty

April M. Arseneau, MD
Valley Allergy and Asthma Clinic
Relevant Relationships: None

Leonard B. Bacharier, MD FAAAAI
Vanderbilt University Medical Center
Relevant Relationships: None

Lori Broderick, MD PhD FAAAAI
University of California - San Diego
Relevant Relationships: None

Gina Brown, MD
Self, Alaska Family Dermatology
Relevant Relationships: None

Jody Butto, MD
Aurora Pediatrics
Relevant Relationships: None

Carla M. Davis, MD FAAAAI
Howard University College of Medicine
Relevant Relationships: None

Jeffrey G. Demain, MD FAAAAI
Lux Infusion
Relevant Relationships: Blueprint Medicine (speaker); Cogent Biosciences, Thermo Fisher (advisory board)

Bryan C. Farthing, PAC
Allergy, Asthma and Immunology Center of Alaska
Relevant Relationships: None

Mitchell H. Grayson, MD FAAAAI
Nationwide Children's Hospital - The Ohio State University
Relevant Relationships: None

Kristina James, MD FAAAAI
Peninsula Allergy & Asthma Center
Relevant Relationships: None

David Kingston, PA-C
Asthma, Allergy, and Immunology Center of Alaska
Relevant Relationships: None

Stephen N. Marks, MD FAAAAI
Allergy, Asthma and Immunology Center of Alaska
Relevant Relationships: None

Gailen D. Marshall Jr., MD PhD FACAAI
University MS Medical Center
Relevant Relationships: None

Peter J. Montesano, MD
Medical Park Family Care
Relevant Relationships: None

Laura M. Moore, MD FAAAAI
Allergy, Asthma and Immunology Center of Alaska, LLC
Relevant Relationships: None

Kari C. Nadeau, MD PhD FAAAAI
Harvard T. H. Chan School of Public Health
Relevant Relationships: None

Kacie Tempel, PA-C
Allergy, Asthma and Immunology Center of AK
Relevant Relationships: None

Sean A. Walsh, PA-C
Allergy, Asthma and Immunology Center of Alaska
Relevant Relationships: None

Jered Weinstock, MD
Providence Alaska Medical Center
Relevant Relationships: None

Kathleen E. Young
WWAMI School of Medical Education
Relevant Relationships: None

 

Content Review

Shirley S. Joo, MD
Internal Medicine Mercy St. Louis
Relevant Relationships: None

Amanda Louise Cox, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Relevant Relationships: Novartis (research grant)

Samuel Gubernick, DO FAAAAI
Family Allergy, Asthma and Immunology Associates
Relevant Relationships: None

Brian C. Schroer, MD FAAAAI
Cleveland Clinic
Relevant Relationships: Ready Set Food (consultant); Allergenis (stocks)

Scott H. Sicherer, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Relevant Relationships: None

Robert S. Zeiger, MD PhD FAAAAI
Kaiser Permanente Southern California
Relevant Relationships: AstraZeneca (consultant)

 

________________________________________
AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
•    Employment. Name of employer and job title.
•    Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
•    Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
•    Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
•    Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
•    Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
•    Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Asthma & Allergy Foundation of America, Alaska Chapter. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 18.25 Contact Hours.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on August 31, 2025. Requests to claim credit on or after October 1, 2025 will be subject to an administrative fee.

Available Credit

  • 18.25 Attendance
    Attendance credit.
  • 18.25 CE
    CE credit.
  • 18.25 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.